ReaCastroMDMPH

Research • Raritan, NJ

Director of Medical Affairs

Join to view full profile

Dr. Castro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Castro's full profile

Already have an account?

Office
1001 US RT 202
Raritan, NJ 08869
Phone+1 224-436-5213

Education & Training

Northern Illinois UniversityMaster in Public Health, Health Services Administration, 2014 - 2016
University of the East College of MedicineClass of 2001
University if Santo TomasBS, Medical Technology, 1993 - 1997

Clinical Trials

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas Start of enrollment: 2015 Feb 17
Completed
Phase 2
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate Start of enrollment: 2015 Dec 01
Active, not recruiting
Phase 3
A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY) Start of enrollment: 2016 Mar 23
Completed
Phase 3
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease Start of enrollment: 2016 May 18
Active, not recruiting
Phase 2
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer Start of enrollment: 2018 Oct 10
Active, not recruiting
Phase 2
Join now to see all

Other Languages

Tagalog